Is Spravato Treatment Right For You?

Are you suffering from Major Depressive Disorder and looking for help? The Counseling Center now offers SPRAVATO® treatment in the Freehold location. Spravato (esketamine) CIII nasal spray is a derivative of ketamine and is the first prescription nasal spray taken with an oral antidepressant for adults with treatment-resistant depression.

How do I Know If I Have Depression?

Major depressive disorder (MDD) is a serious condition that affects 16 million people in the United States alone. Symptoms for adults suffering from Major Depressive Disorder include feelings of sadness, lack of energy, disrupted sleep, lack of interest or inability to feel pleasure, and even regular suicidal thoughts or actions. Oral antidepressants have long been the best practice in the treatment of MDD, but results vary greatly, and in some cases they are ineffective. Treatment resistant depression (TRD), a type of major depressive disorder, describes depression that has failed to respond to two or more different treatment approaches. TRD affects up to one-third of adults who suffer from major depression.

Benefits of SPRAVATO for Treating Depression

Ketamine Room 

Those who took SPRAVATO and an oral antidepressant experienced reductions in depressive symptoms at four weeks compared to those who received a placebo plus an oral antidepressant. Clinical studies have shown the benefits of SPRAVATO can be experienced within 24 hours of the first treatment. SPRAVATO targets the N-methyl-D-aspartate (NMDA) receptor and is believed to work differently than currently available oral antidepressants.

*Insurance and Self-Pay options are available.